Dr. Michael Hanbury

• 
  www.healthdiscoverycorp.com/bod.php - [Cached Version]
  Published on: 11/17/2008    Last Visited: 11/17/2008  

  Dr. Michael Hanbury

• 
  www.healthdiscoverycorp.com/bios/bio-hanbury.html - [Cached Version]
  Published on: 11/2/2005    Last Visited: 11/17/2008  

  Dr. Michael Hanbury Director
  
  Dr. Hanbury has over 25 years professional and associated corporate management experience in medical diagnostic and clinical laboratory sectors with a diverse experience base including successful tenures in research and direct patient care in nationally renowned academic medical centers; operations management in public and private clinical laboratories; and concept-to-market design, development, customer support, engineering, compliance and regulatory management in in-vitro diagnostic manufacturing companies.
  
  In addition to substantial academic research experience, he has directed all US operations for an international in-vitro diagnostics company and managed regulatory affairs for Roche Molecular Systems, where his efforts were instrumental in obtaining the first FDA clearances for some of the most widely used commercial molecular diagnostic products on the market. Before its acquisition by Quest Diagnostics, he was Chief Operating Officer of Unilab Corporation, formerly the third largest reference laboratory in the country operating 51 laboratories with revenue exceeding $600 million annually. He also remains operating Principal at HCC Consulting providing operating and regulatory services to a number of recognized clinical laboratories and IVD clients and he continues to serve on the Board of Alexeter Technologies.
  
  Dr. Hanbury is currently President, CEO and a shareholder of DCL Medical Laboratories in Indianapolis, IN. Dr. Hanbury completed his undergraduate studies at the University of Virginia in Biochemistry and Economics and graduate studies at the Medical College of Virginia where he also completed his clinical training. He also holds Masters Degrees in Clinical Chemistry and a MBA from ODU/Eastern Virginia Medical School and Michigan, respectively.

• 
  AD PathLabs Names Hanbury Chief Operating Officer - [Cached Version]
  Published on: 6/10/2003    Last Visited: 6/10/2003  

  NEWPORT BEACH, Calif., June 10 /PRNewswire/ -- AD PathLabs, a leading-edge provider of outsourced anatomic pathology services, has appointed Michael Hanbury, Ph.D., as chief operating officer of the Newport Beach-based company.
  ...
  Dr. Hanbury comes to AD PathLabs with more than 18 years of professional clinical and operational management experience in diverse business and scientific settings.His experience includes nationally recognized academic medical centers, national clinical diagnostic reference laboratories and in- vitro diagnostic product manufacturing, operations and regulatory affairs.
  
  "AD PathLabs has developed a partnership model with local hospitals and associated pathologists to provide personalized, responsive and scientifically advanced anatomic pathology and cytology services to the patients we collectively serve," said Dr. Hanbury."I look forward to continuing the growth of AD PathLabs with our physician and hospital partners through focused investment in new testing areas and expansion into other medical markets."
  
  Prior to joining AD PathLabs, Dr. Hanbury was senior vice president of laboratory operations and chief scientific officer for Unilab Corp. in California, now a part of Quest Diagnostics.There, he directed technical and laboratory operations and corporate standardization for over 50 commercial clinical laboratories with combined annual sales exceeding $400 million.
  
  "Dr. Hanbury is highly recognized in the industry and brings a broad range of experience to our growing management team," said Charles Madden, president of AD PathLabs.

• 
  BioCrossroads - Success Stories Page - [Cached Version]
  Published on: 11/30/2006    Last Visited: 10/16/2008  

  Michael Hanbury CEO

• 
  Calypte Biomedical Corporation Press Release - [Cached Version]
  Published on: 1/30/2002    Last Visited: 8/7/2007  

  "Unilab is pleased to be California's first laboratory to offer Calypte's urine HIV-1 test state-wide," said Dr. Michael Hanbury, Unilab senior vice president and chief scientific officer."Calypte's urine HIV-1 screening test and Western Blot confirmatory tests have received clearance for use by the FDA and have demonstrated substantially equivalent performance to serum tests in clinical trials reported in the literature and conducted by Unilab.Urine provides an excellent alternative for sexually transmitted disease screening and can now be used for HIV in conjunction with Unilab's amplified molecular testing capabilities for chlamydia and gonorrhea for adolescent and male patients, thus furthering access for screening patients at risk for sexually transmitted diseases.The addition of the urine HIV test to Unilab's testing portfolio will simplify and provide greater access for sexually transmitted disease screening to patients throughout California and Arizona," he added.
  
  Through sales and marketing programs, Calypte has generated interest in urine HIV testing among Community Based Organizations and AIDS Service Organizations.

• 
  DCL - Corporate Management - [Cached Version]
  Published on: 10/10/2008    Last Visited: 10/10/2008  

  Dr. Michael HanburyPresident and CEODr. Hanbury has over 25 years professional and associated corporate management experience in medical diagnostic and clinical laboratory sectors.Before joining DCL in January 2007, he was Corporate Senior Vice President and Chief Scientific Officer of Unilab Corporation, formerly the third largest reference laboratory in the country operating 51 laboratories producing over 35 million tests with revenue exceeding $600 million annually.Previously, Dr. Hanbury held Chief Operating Officer and Business Development roles in a number of emerging laboratories in California including AD Pathlabs and Westcliff Medical Laboratories.Previously, he held management positions in regulatory affairs at Roche Diagnostics, Roche Biomedical Laboratories and managed North American operations for an international device manufacturer.Dr. Hanbury completed his undergraduate studies at the University of Virginia in Chemistry and graduate program in Clinical Pathology from the Medical College of Virginia.He also holds Masters Degrees in Clinical Chemistry and Business from Old Dominion University/Eastern Virginia Medical School and Central Michigan University, respectively.

• 
  Health Discovery Corporation - [Cached Version]
  Last Visited: 11/17/2008  

  "DCL is pleased to partner with Health Discovery Corporation in the development of novel computer based imaging systems to improve the sensitivity for the detection of cervical cancer," said Dr. Michael Hanbury, President and Chief Executive Officer of DCL.
  ...
  Dr. Michael Hanbury, 317-874-1300

• 
  Health Discovery Corporation - [Cached Version]
  Last Visited: 11/17/2008  

  "DCL is pleased to expand our partnership with Health Discovery Corporation in the development of novel computer based imaging systems", said Dr. Michael Hanbury, President and Chief Executive Officer of DCL.

• 
  March 20, 2008 - [Cached Version]
  Published on: 3/20/2008    Last Visited: 5/10/2008  

  "DCL is pleased to join Third Wave in this novel strategic relationship," said Dr. Michael Hanbury, president and chief executive of DCL.

• 
  Third Wave Technologies :: Investor Relations :: Press... - [Cached Version]
  Published on: 3/20/2008    Last Visited: 7/31/2008  

  "DCL is pleased to join Third Wave in this novel strategic relationship," said Dr. Michael Hanbury, president and chief executive of DCL.
  ...
  Dr. Michael Hanbury(317) 874-1300

Page:  1 2